EPO Patents = 3

Forward Citations = 1

Loading Chart...

4 inventors (with patents filed for the assignee):

Kai Zhang (3 out of 831 patents)

Michael Niesman (3 out of 4 patents)

Kay Olmstead (2 out of 16 patents)

4. Julian Northen (2 out of 2 patents)

5 patents: Sort by Forward Citations

1. 12415807 - PKC inhibitor solid state forms (2025-09-16),

2. 11154555 - Treatment of cancer (2021-10-26),

3. 11104679 - PKC inhibitor solid state forms (2021-08-31),

4. 9980965 - Treatment of autoimmune disease (2018-05-29),

5. 9814716 - Treatment of autoimmune disease (2017-11-14),

Mingsight Pharmaceuticals, Inc. is a leading biopharmaceutical company dedicated to discovering, developing, and commercializing innovative medicines to address unmet medical needs. Founded in 2005, we focus on research in oncology, infectious diseases, and rare genetic disorders. Our mission is to improve patient outcomes and enhance the quality of life through our cutting-edge therapies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

5 Patents

#847 in San Diego, CA

#11,741 in California

#50,237 in US

San Diego, CA, United States of America

Mingsight Pharmaceuticals, Inc.

Forward Citations = 1

4 inventors:

Kai Zhang (3 out of 831 patents)

Michael Niesman (3 out of 4 patents)

Kay Olmstead (2 out of 16 patents)

4. Julian Northen (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

3 patents (EPO):

Please report any incorrect information to support@idiyas.com